A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
Condition: Bioequivalence Interventions: Drug: Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use; Drug: Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use Sponsors: Pharmtechnology LLC; Altasciences Company Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2019 Category: Research Source Type: clinical trials
The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Condition: Bioequivalence Interventions: Drug: Olmesartan Medoxomil 40 mg; Drug: Olmetec® Sponsors: Pharmtechnology LLC; Altasciences Company Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2019 Category: Research Source Type: clinical trials